Skip to main content
Erschienen in: Journal of Cardiovascular Translational Research 3/2012

01.06.2012

Economic Methods in the Century Trial—a Comprehensive Lifestyle Modification Study for Managing Coronary Artery Disease

verfasst von: James R. Langabeer II, Rigoberto Delgado, David Lairson, Nils P Johnson, K. Lance Gould, Stefano M. Sdringola

Erschienen in: Journal of Cardiovascular Translational Research | Ausgabe 3/2012

Einloggen, um Zugang zu erhalten

Abstract

While most studies assess the cost-effectiveness of treating acute coronary conditions, the Century Health Study for Cardiovascular Medicine (Century Trial) focuses on ameliorating coronary artery disease (CAD) through a comprehensive lifestyle modification program. This 1,300-patient phase III randomized study uses positron emission tomography for risk stratification, complemented with comprehensive educational and motivational therapy for patients with preclinical or established CAD. The Century Trial is in its second year of a five-year follow-up protocol, and it is one of the first to combine imaging technology and lifestyle modification as a way to improve patient behavior and health. In this article, we present the economic study design used in the Century Trial and provide considerable methodological detail to serve as reference for other researchers. We describe the cost and effect estimation methods as well as our analysis and uncertainty modeling plans. The study will incorporate quality-adjusted life years and use a societal perspective to measure both in-trial and lifetime costs through incremental cost-effectiveness ratios. The approach we follow should provide further evidence on the cost-effectiveness of comprehensive lifestyle modification programs in regressing coronary artery disease.
Literatur
1.
Zurück zum Zitat National Center for Health Statistics. (2007). Health, United States, with Chartbook on Trends in the Health of Americans. National Center for Health Statistics. (2007). Health, United States, with Chartbook on Trends in the Health of Americans.
2.
Zurück zum Zitat Agency for Healthcare Research and Quality. (2006). The high concentration of U.S. health care expenditures. AHHQ Research in Action Report, 19, 1–12. Agency for Healthcare Research and Quality. (2006). The high concentration of U.S. health care expenditures. AHHQ Research in Action Report, 19, 1–12.
3.
Zurück zum Zitat Nissen, S. E., Nicholls, S. J., Sipahi, I., Libby, P., Raichlen, J. S., Ballantyne, C. M., et al. (2006). Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: The ASTEROID trial. Journal of the American Medical Association, 295(13), 1556–1565.PubMedCrossRef Nissen, S. E., Nicholls, S. J., Sipahi, I., Libby, P., Raichlen, J. S., Ballantyne, C. M., et al. (2006). Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: The ASTEROID trial. Journal of the American Medical Association, 295(13), 1556–1565.PubMedCrossRef
4.
Zurück zum Zitat Nicholls, S. J., Tuzcu, E. M., Sipahi, I., Grasso, A. W., Schoenhagen, P., Hu, T., et al. (2007). Statins, high-density lipoprotein cholesterol, and regression of coronary atherosclerosis. Journal of the American Medical Association, 297(5), 499–508.PubMedCrossRef Nicholls, S. J., Tuzcu, E. M., Sipahi, I., Grasso, A. W., Schoenhagen, P., Hu, T., et al. (2007). Statins, high-density lipoprotein cholesterol, and regression of coronary atherosclerosis. Journal of the American Medical Association, 297(5), 499–508.PubMedCrossRef
5.
Zurück zum Zitat Sdringola, S., Nakagawa, K., Nakagawa, Y., Kirkeeidee, R., Yusuf, W., Haynie, M., et al. (2003). Combined intense lifestyle and pharmacologic lipid treatment further reduce coronary events and myocardial perfusion abnormalities compared with usual-care cholesterol-lowering drugs in coronary artery disease. Journal of the American College of Cardiology, 41, 263–272.PubMedCrossRef Sdringola, S., Nakagawa, K., Nakagawa, Y., Kirkeeidee, R., Yusuf, W., Haynie, M., et al. (2003). Combined intense lifestyle and pharmacologic lipid treatment further reduce coronary events and myocardial perfusion abnormalities compared with usual-care cholesterol-lowering drugs in coronary artery disease. Journal of the American College of Cardiology, 41, 263–272.PubMedCrossRef
6.
Zurück zum Zitat Sdringola, S., Loghin, C., Boccalandro, F., & Gould, K. L. (2006). Mechanisms of progression and regression of coronary artery disease by PET related to treatment intensity and clinical events at long-term follow-up. Journal of Nuclear Medicine, 47, 59–67.PubMed Sdringola, S., Loghin, C., Boccalandro, F., & Gould, K. L. (2006). Mechanisms of progression and regression of coronary artery disease by PET related to treatment intensity and clinical events at long-term follow-up. Journal of Nuclear Medicine, 47, 59–67.PubMed
7.
Zurück zum Zitat Gould, K. L., Ornish, D., Scherwitz, L., Brown, S., Edens, R. P., Hess, M. J., et al. (1995). Changes in myocardial perfusion abnormalities by positron emission tomography after long-term, intense risk factor modification. Journal of the American Medical Association, 274, 894–901.PubMedCrossRef Gould, K. L., Ornish, D., Scherwitz, L., Brown, S., Edens, R. P., Hess, M. J., et al. (1995). Changes in myocardial perfusion abnormalities by positron emission tomography after long-term, intense risk factor modification. Journal of the American Medical Association, 274, 894–901.PubMedCrossRef
8.
Zurück zum Zitat Hu, F. B., & Willet, W. C. (2002). Optimal diets for prevention of coronary artery disease. Journal of the American Medical Association, 288, 2569–2578.PubMedCrossRef Hu, F. B., & Willet, W. C. (2002). Optimal diets for prevention of coronary artery disease. Journal of the American Medical Association, 288, 2569–2578.PubMedCrossRef
9.
Zurück zum Zitat Parikh, P., McDaniel, M. C., Ashen, M. D., Miller, J. I., Sorrentino, M., Chan, V., et al. (2005). Diets and cardiovascular disease. An evidence-based assessment. Journal of the American College of Cardiology, 45, 1379–1387.PubMedCrossRef Parikh, P., McDaniel, M. C., Ashen, M. D., Miller, J. I., Sorrentino, M., Chan, V., et al. (2005). Diets and cardiovascular disease. An evidence-based assessment. Journal of the American College of Cardiology, 45, 1379–1387.PubMedCrossRef
10.
Zurück zum Zitat Krauss, R. M., Eckel, R. H., Howard, B., Appel, L. J., Daniels, S. R., Deckelbaum, R. J., et al. (2000). AHA guidelines: Revision 2000: A statement for healthcare professionals from the nutrition committee of the American heart association. Circulation, 102, 2284–2299.PubMed Krauss, R. M., Eckel, R. H., Howard, B., Appel, L. J., Daniels, S. R., Deckelbaum, R. J., et al. (2000). AHA guidelines: Revision 2000: A statement for healthcare professionals from the nutrition committee of the American heart association. Circulation, 102, 2284–2299.PubMed
11.
Zurück zum Zitat Kokkinos, P., Myers, J., Kokkinos, J. P., Pittaras, A., Narayan, P., Manolis, A., et al. (2008). Exercise capacity and mortality in black and white men. Circulation, 117, 614–622.PubMedCrossRef Kokkinos, P., Myers, J., Kokkinos, J. P., Pittaras, A., Narayan, P., Manolis, A., et al. (2008). Exercise capacity and mortality in black and white men. Circulation, 117, 614–622.PubMedCrossRef
12.
Zurück zum Zitat Blair, S. N., Kohl, H. W., Barlow, C. E., Paffenbarger, R. S., Gibbons, L. W., & Macera, C. A. (1995). Changes in physical fitness and all-cause mortality. A prospective study of health and unhealthy men. Journal of the American Medical Association, 273, 1093–1098.PubMedCrossRef Blair, S. N., Kohl, H. W., Barlow, C. E., Paffenbarger, R. S., Gibbons, L. W., & Macera, C. A. (1995). Changes in physical fitness and all-cause mortality. A prospective study of health and unhealthy men. Journal of the American Medical Association, 273, 1093–1098.PubMedCrossRef
13.
Zurück zum Zitat Czernin, J., Barnard, J., Sun, K. T., Krivokapich, J., Nitzsche, E., Dorsey, D., et al. (1995). Effects of short-term cardiovascular conditioning and low fat diet on myocardial blood flow and flow reserve. Circulation, 92, 197–204.PubMed Czernin, J., Barnard, J., Sun, K. T., Krivokapich, J., Nitzsche, E., Dorsey, D., et al. (1995). Effects of short-term cardiovascular conditioning and low fat diet on myocardial blood flow and flow reserve. Circulation, 92, 197–204.PubMed
14.
Zurück zum Zitat Fletcher, G. F., Balady, G., Blair, S. N., Blumenthal, J., Caspersen, C., Shaitman, B., et al. (1996). Statement on exercise: Benefits and recommendations for physical activity programs for all Americans. Circulation, 94, 857–862.PubMed Fletcher, G. F., Balady, G., Blair, S. N., Blumenthal, J., Caspersen, C., Shaitman, B., et al. (1996). Statement on exercise: Benefits and recommendations for physical activity programs for all Americans. Circulation, 94, 857–862.PubMed
15.
Zurück zum Zitat Ornish, D., Scherwitz, L., Brown, S., Billings, J., Armstrong, W. T., Ports, T. A., et al. (1990). Can lifestyle changes reverse atherosclerosis? Lancet, 336, 129–133.PubMedCrossRef Ornish, D., Scherwitz, L., Brown, S., Billings, J., Armstrong, W. T., Ports, T. A., et al. (1990). Can lifestyle changes reverse atherosclerosis? Lancet, 336, 129–133.PubMedCrossRef
16.
Zurück zum Zitat Shrewsburry, V. A., O’Oconnor, J., Steinbeck, K. S., Stevenson, K., Lee, A., Hill, A. J., et al. (2009). A randomized controlled trial of a community-based healthy lifestyle program for overweight and obese adolescents: The Loozit study protocol. BMC Public Health. doi:10.1186/1471-2458-9-119. Shrewsburry, V. A., O’Oconnor, J., Steinbeck, K. S., Stevenson, K., Lee, A., Hill, A. J., et al. (2009). A randomized controlled trial of a community-based healthy lifestyle program for overweight and obese adolescents: The Loozit study protocol. BMC Public Health. doi:10.​1186/​1471-2458-9-119.
17.
Zurück zum Zitat Raynor, H. A., Kilanowski, C. K., Esterlis, I., & Epstein, L. H. (2002). A cost-analysis of adopting a healthful diet in a family-based obesity treatment program. Journal of the American Dietetic Association, 102, 645–656.PubMedCrossRef Raynor, H. A., Kilanowski, C. K., Esterlis, I., & Epstein, L. H. (2002). A cost-analysis of adopting a healthful diet in a family-based obesity treatment program. Journal of the American Dietetic Association, 102, 645–656.PubMedCrossRef
18.
Zurück zum Zitat Siegel, J., Weinstein, M., Russell, L., & Gold, M. (1996). Recommendations for reporting cost-effectiveness analyses. Journal of the American Medical Association, 276, 1339–1341.PubMedCrossRef Siegel, J., Weinstein, M., Russell, L., & Gold, M. (1996). Recommendations for reporting cost-effectiveness analyses. Journal of the American Medical Association, 276, 1339–1341.PubMedCrossRef
19.
Zurück zum Zitat Ramsey, S., Wilke, R., Briggs, A., Brown, R., Buxton, M., Chawla, A., et al. (2005). Good research practices for cost-effectiveness analysis alongside clinical trials: The ISPOR RCT-CEA task force report. Value in Health, 8(5), 521–533.PubMedCrossRef Ramsey, S., Wilke, R., Briggs, A., Brown, R., Buxton, M., Chawla, A., et al. (2005). Good research practices for cost-effectiveness analysis alongside clinical trials: The ISPOR RCT-CEA task force report. Value in Health, 8(5), 521–533.PubMedCrossRef
20.
Zurück zum Zitat Gray, A. M., Clarke, P. M., Wolstenholme, J. L., & Wordsworth, S. (2011). Applied methods of cost-effectiveness analysis in health care. New York: Oxford University Press. Gray, A. M., Clarke, P. M., Wolstenholme, J. L., & Wordsworth, S. (2011). Applied methods of cost-effectiveness analysis in health care. New York: Oxford University Press.
21.
Zurück zum Zitat Lairson, D. R., Basu, R., Begley, C. E., & Reynolds, T. (2009). Concordance of survey and billing data in a study of outpatient healthcare cost and utilization among epilepsy patients. Epilepsy Research, 87, 59–69.PubMedCrossRef Lairson, D. R., Basu, R., Begley, C. E., & Reynolds, T. (2009). Concordance of survey and billing data in a study of outpatient healthcare cost and utilization among epilepsy patients. Epilepsy Research, 87, 59–69.PubMedCrossRef
22.
Zurück zum Zitat Thompson Reuters (2010). Red Book 2010: pharmacy’s fundamental reference. CD-ROM. Thompson Reuters. Thompson Reuters (2010). Red Book 2010: pharmacy’s fundamental reference. CD-ROM. Thompson Reuters.
24.
Zurück zum Zitat Glaser, R., Glick, H., Hermann, H., & Kimmell, S. (2006). The role of risk stratification in the decision to provide upstream versus selective glycoprotein IIb/IIIa inhibitors for acute coronary syndromes: A cost-effectiveness analysis. Journal of the American College of Cardiology, 47(3), 529–537.PubMedCrossRef Glaser, R., Glick, H., Hermann, H., & Kimmell, S. (2006). The role of risk stratification in the decision to provide upstream versus selective glycoprotein IIb/IIIa inhibitors for acute coronary syndromes: A cost-effectiveness analysis. Journal of the American College of Cardiology, 47(3), 529–537.PubMedCrossRef
25.
Zurück zum Zitat Spertus, J., Jones, P., McDonell, M., Fan, V., & Fihn, S. (2002). Health status predicts long-term outcomes in coronary artery disease. Circulation, 106, 43–49.PubMedCrossRef Spertus, J., Jones, P., McDonell, M., Fan, V., & Fihn, S. (2002). Health status predicts long-term outcomes in coronary artery disease. Circulation, 106, 43–49.PubMedCrossRef
26.
Zurück zum Zitat Briggs, A. H. (2001). Handling uncertainty in economic evaluation and presenting the results. In M. Drummond & A. McGuire (Eds.), Economic evaluation in health care (pp. 172–214). New York: Oxford University Press. Briggs, A. H. (2001). Handling uncertainty in economic evaluation and presenting the results. In M. Drummond & A. McGuire (Eds.), Economic evaluation in health care (pp. 172–214). New York: Oxford University Press.
Metadaten
Titel
Economic Methods in the Century Trial—a Comprehensive Lifestyle Modification Study for Managing Coronary Artery Disease
verfasst von
James R. Langabeer II
Rigoberto Delgado
David Lairson
Nils P Johnson
K. Lance Gould
Stefano M. Sdringola
Publikationsdatum
01.06.2012
Verlag
Springer US
Erschienen in
Journal of Cardiovascular Translational Research / Ausgabe 3/2012
Print ISSN: 1937-5387
Elektronische ISSN: 1937-5395
DOI
https://doi.org/10.1007/s12265-012-9355-x

Weitere Artikel der Ausgabe 3/2012

Journal of Cardiovascular Translational Research 3/2012 Zur Ausgabe

„Jeder Fall von plötzlichem Tod muss obduziert werden!“

17.05.2024 Plötzlicher Herztod Nachrichten

Ein signifikanter Anteil der Fälle von plötzlichem Herztod ist genetisch bedingt. Um ihre Verwandten vor diesem Schicksal zu bewahren, sollten jüngere Personen, die plötzlich unerwartet versterben, ausnahmslos einer Autopsie unterzogen werden.

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Thrombektomie auch bei großen Infarkten von Vorteil

16.05.2024 Ischämischer Schlaganfall Nachrichten

Auch ein sehr ausgedehnter ischämischer Schlaganfall scheint an sich kein Grund zu sein, von einer mechanischen Thrombektomie abzusehen. Dafür spricht die LASTE-Studie, an der Patienten und Patientinnen mit einem ASPECTS von maximal 5 beteiligt waren.

Herzinfarkt mit 85 – trotzdem noch intensive Lipidsenkung?

16.05.2024 Hypercholesterinämie Nachrichten

Profitieren nach einem akuten Myokardinfarkt auch Betroffene über 80 Jahre noch von einer intensiven Lipidsenkung zur Sekundärprävention? Um diese Frage zu beantworten, wurden jetzt Registerdaten aus Frankreich ausgewertet.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.